Ex Parte Daluge et al - Page 2




              Appeal No. 2005-0838                                                                                        
              Application No. 10/174,414                                                                                  


              will consider the issues as they apply to representative claims 18 and 27, which read as                    
              follows:                                                                                                    
              18. (Appealed) A method for the prophylaxis of an inflammatory condition or                                 
                     immune disorder associated with infiltration of Ieukocytes into inflamed tissue                      
                     in a subject in need thereof which method comprises administering to said                            
                     subject a therapeutically effective amount of a compound of formula (1):                             








                     or a solvate thereof wherein:                                                                        
                     X is -0- or -NH-;                                                                                    
                     Q is (-CH2-)p, (-CH=CH-)p, (-C/C-)p where p is an integer of from 0 to 4;                            
                     R1 is hydrogen or methyl;                                                                            
                     R2 and R3 independently represent 0 or S;                                                            
                     n is an integer of 1 to 50: and                                                                      
                     R is hydrogen or methyl.                                                                             

                     27. (Appealed) A method for the prophylaxis or treatment of Crohn's disease in a                     
                     subject in need thereof which comprises administering to said subject a                              
                     therapeutically effective amount of a compound of formula (1):                                       








                                                            2                                                             





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007